Donald Olds - Aug 31, 2023 Form 4 Insider Report for Acasti Pharma Inc. (ACST)

Role
Director
Signature
/s/ Prashant Kohli, as attorney-in-fact
Stock symbol
ACST
Transactions as of
Aug 31, 2023
Transactions value $
$781
Form type
4
Date filed
9/5/2023, 03:54 PM
Previous filing
Jul 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACST Common Shares Purchase $781 +381 $2.05 381 Aug 31, 2023 Direct
holding ACST Common Shares 792 Aug 31, 2023 Ofra Aslan (Spouse) F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These indirect holdings have been adjusted to give effect to the Company's 1-for-8 reverse stock split, effective August 31, 2021, and the Company's 1-for-6 reverse stock split, effective July 10, 2023.
F2 792 common shares held by Mr. Olds' wife, Ofra Aslan. Mr. Olds disclaims beneficial ownership of the common shares held by his wife and this report shall not be deemed an admission that Mr. Olds is a beneficial owner of such for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.